Proposal 1 - To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation,as amended, to effect a reverse split of our outstanding common stock at a ratio in the range of 1-for-50 to1-for-100, to be determined at the discretion of our Board of Directors, whereby each outstanding 50 to100 common shares would be combined, converted and changed into 1 share of our common stock, to enable the Company to comply with the Nasdaq Stock Market’s continued listing requirements;
• Proposal 2 - To approve an amendment to the Company’s 2017 Equity Incentive Plan to provide that the Incentive Stock Option Limit set forth in Section 3(c) of the Company’s 2017 Equity Incentive Plan shall not be subject to adjustment pursuant to the applicable provisions of Section 9(a)(i) of the Company’s 2017 Equity Incentive Plan in connection with the reverse stock split effected by the Company on October 16, 2020 or the first reverse stock split effected by the Company following December 5, 2022; and
• Proposal 3 - To authorize one or more adjournments of the special meeting to solicit additional proxies in the event there are insufficient votes to approve Proposal 1 and Proposal 2 described above.
Recent NUWE News
- Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference • GlobeNewswire Inc. • 09/25/2024 08:15:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/30/2024 08:11:06 PM
- New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy • GlobeNewswire Inc. • 08/27/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:45:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/24/2024 01:31:56 AM
- Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 08/23/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 09:10:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 05:00:16 PM
- Nuwellis, Inc. Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:15:42 PM
- Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions • GlobeNewswire Inc. • 08/08/2024 01:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/02/2024 08:12:11 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2024 07:05:58 PM
- Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/25/2024 01:25:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 12:31:38 PM
- Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/24/2024 12:02:35 PM
- Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024 • GlobeNewswire Inc. • 07/23/2024 08:10:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/17/2024 08:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 01:12:51 PM
- Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s • GlobeNewswire Inc. • 07/17/2024 01:00:00 PM
- SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner • GlobeNewswire Inc. • 07/12/2024 12:30:00 PM
- New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference • GlobeNewswire Inc. • 07/09/2024 01:00:00 PM
- Nuwellis Announces Reverse Stock Split • GlobeNewswire Inc. • 06/26/2024 12:45:00 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM